Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
CarboCode
AddedMay 15, 2026
UpdatedJul 17, 2026
CarboCode

CarboCode

Series C

CarboCode produces human-identical bioactive sphingolipids for nutrition, skin health, and human wellness.

HQ
Cantanhede, Coimbra, PT
Founded
2017
Overview
Compare
Fundraising
Employees
News
Website

CarboCode is a biotechnology company harnessing the power of human sphingolipids to produce human-identical bioactive lipids for better nutrition, skin health, and human wellness. Founded in 2017 by experienced scientists and engineers, the company integrates core competences in biocatalysis, fermentation, protein and metabolic engineering, and chemistry to produce many classes of human sphingolipids at industrial scale.

CarboCode serves three key segments: skin care through ceramides essential to healthy skin, infant nutrition by offering human milk gangliosides that play an essential role in baby development, and adult nutrition where gangliosides support brain function and gastrointestinal health. With more than 60 highly skilled employees of about 10 nationalities, CarboCode continues to develop clinically proven product solutions for its customers.

CarboCode - Similar Companies

Conagen logo

Conagen

Carmolex logo

Carmolex

CellType logo

CellType

celltype.com

BodyBio logo

BodyBio

bodybio.co.uk

Code Biotherapeutics logo

Code Biotherapeutics

codebiotx.com

AivoCode logo

AivoCode

aivocode.com

Glycos Biotechnologies logo

Glycos Biotechnologies

glycosbio.com

Cellibre logo

Cellibre

cellibre.com

NouBio logo

NouBio

noubio.co

NatGlycan logo

NatGlycan

Spheringenics logo

Spheringenics

Codetta logo

Codetta

codettabio.com

Cell-Free Bioinnovations logo

Cell-Free Bioinnovations

cfb9.com

CasTag Biosciences logo

CasTag Biosciences

Encodia logo

Encodia

encodia.com

CarboCode - Quick Facts

Who are CarboCode's competitors?

Companies similar to CarboCode include Conagen, Carmolex, CellType and BodyBio.

When was CarboCode founded?

CarboCode was founded in 2017.

Where is CarboCode's headquarters located?

CarboCode's headquarters is located in Cantanhede, Coimbra, PT.

When was CarboCode's last funding round?

CarboCode's most recent funding round was for $15M (USD) in December 2024.

How much has CarboCode raised to-date?

As of Dec 4, 2024, CarboCode has raised a total of $15M (USD).

How many employees does CarboCode have?

CarboCode has 35 employees as of May 16, 2026.

CarboCode - Classification

Industry
  • Biotechnology